Search

Your search keyword '"Peter R. Carroll"' showing total 1,333 results

Search Constraints

Start Over You searched for: Author "Peter R. Carroll" Remove constraint Author: "Peter R. Carroll"
1,333 results on '"Peter R. Carroll"'

Search Results

1. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

2. Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study

3. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States

4. Ten‐year work burden after prostate cancer treatment

5. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer

6. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low‐ and very‐low risk prostate cancer

7. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

8. Controlled trial of decision support for men with early-stage prostate cancer: brief research report of effects on patient knowledge

9. Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey

10. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer

11. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

12. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial

13. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

14. Genetic factors associated with prostate cancer conversion from active surveillance to treatment

15. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer

16. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients

17. Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort

18. Effect of Oscillation on Perineal Pressure in Cyclists: Implications for Micro-Trauma

19. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

20. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study

21. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer

22. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction

23. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

24. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

25. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

26. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

27. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

28. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

29. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

30. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

31. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

32. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

33. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

34. Urovysion™ testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer

35. Genomic Profiling of Hormone-Naïve Lymph Node Metastases in Patients with Prostate Cancer

37. Detection of clinically significant prostate cancer with PI-RADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions

40. Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system’s electronic medical record?

41. Prostate-Specific Antigen Screening in Transgender Patients

42. Health Literacy and Appropriateness of <scp>Self‐Care</scp> and Pain Management in Osteoarthritis: An Understanding of the Patient's Perspective

44. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for 'large' cribriform prostatic adenocarcinoma

46. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death

50. Data from Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer

Catalog

Books, media, physical & digital resources